Gts Securities LLC Cytokinetics Inc Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$51.22 - $60.16 $855,374 - $1 Million	16,700 Added 88.83%	35,500 $1.87 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $9.39 Million - $14.7 Million	-196,200 Reduced 91.26%	18,800 $1.02 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $4.49 Million - $7.62 Million	-70,500 Reduced 24.69%	215,000 $15.1 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $7.4 Million - $23 Million	275,300 Added 2699.02%	285,500 $23.8 Million
Q3 2023 Nov 15, 2023	BUY	$29.46 - $36.61 $300,492 - $373,422	10,200 New	10,200 $300,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.